Daily Cancer News

OMNI Health Media is a leading online provider of Daily Cancer News. OMNI’s Daily Cancer News provides summaries of new treatment strategies as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating cancer therapies and supportive care strategies, to better educate patients and their caregivers, ensuring timely access to the best cancer care available.

CancerConnect Cancer Commuity & Discussions

Share


Latest Cancer News


Votrient® plus Taxol® Promising in Relapsed and Refractory Bladder Cancer (March 30, 2015)

The treatment combination of Votrient® (pazopanib) plus Taxol® (paclitaxel) appears active against bladder cancer that has not responded to or come back after previous therapy. These findings were presented... Continue Reading

OmniHealth Media Announces Opportunity for Polycythemia Vera Patients to Provide Important Insight to Improve Outcomes (March 27, 2015)

Sun Valley, Idaho and Fort Worth, Texas – OmniHealth Media announces the opportunity for polycythemia vera patients to share treatment experience and insight about current and future treatment of PV.... Continue Reading

Cytosponge Offers Minimally Invasive Screening Option for Barrett’s Esophagus (March 26, 2015)

Screening for Barrett’s esophagus with a new device called a Cytosponge is accurate compared to endoscopy but less expensive and easier on patients. These findings were reported in the journal PLoS Medicine. Barrett’s... Continue Reading

Pacritinib May Be Effective against Myelofibrosis without Risk of Myelosuppression (March 25, 2015)

The investigational agent pacritinib appears active against myelofibrosis without the risk of myelosuppression, a common side effect of many drugs used to treat myelofibrosis and other myeloproliferative... Continue Reading

Herceptin Superior to Tykerb for Treatment of HER2-positive Breast Cancer (March 24, 2015)

CancerConnect News: In patients with human epidermal growth factor receptor (HER2)–positive advanced breast cancer, the combination of Herceptin® (trastuzumab) plus a taxane resulted in delayed time... Continue Reading

Treatment Outcomes in Stage III Colon Cancer Appear Better in Aspirin, COX-2 Inhibitor Users (March 23, 2015)

CancerConnect News:   According to the results of a study recently reported in the Journal of the National Cancer Institute, patients with stage III colon cancer who take aspirin or other agents that... Continue Reading

Have a Question about Polycythemia Vera? Ask the Expert! (March 20, 2015)

CancerConnect Presents: Ask the Expert with Dr. Mesa CancerConnect announces the opportunity to engage with a polycythemia vera (PV) expert, Ruben A. Mesa, MD. On April 29, 2015, Dr. Mesa will answer your... Continue Reading

Preoperative Arterial Chemotherapy Appears Superior to Post-operative Chemotherapy in the Management of Early Stage Colorectal Cancer (March 18, 2015)

CancerConnect News: Doctors from China have reported at the annual Gastrointestinal Cancers Symposium sponsored by the American Society of Clinical Oncology in San Francisco that giving preoperative chemotherapy... Continue Reading

XBiotech Launches Website and Call Center to Facilitate Recruitment for U.S. Phase III Study of Xilonix™ in Metastatic Colorectal Cancer (March 17, 2015)

AUSTIN, Texas, March 12, 2015—XBiotech announced today that it has launched a website and call center to help patients with metastatic colorectal cancer learn about its U.S. Pivotal Phase III clinical... Continue Reading

Sutent® Maintenance Therapy Found Active in Small-Cell Lung Cancer (March 17, 2015)

Cancer Connect: Doctors have reported that maintenance therapy using Sutent® (sunitinib) delays the time to cancer progression and improves survival in patients with extensive-stage small-cell lung cancer... Continue Reading

Cyramza® plus Taxotere® Promising in Advanced Bladder Cancer (March 16, 2015)

The treatment combination of Cyramza® (ramucirumab) plus Taxotere® (docetaxel) appears to extend progression-free survival in patients with advanced bladder cancer that has relapse after previous treatment.... Continue Reading

Colorectal Cancer Talk: Are You At High Risk? (March 16, 2015)

Join the Experts for a LIVE Online Video Chat Colorectal cancer screening should begin at age 50 for those at average risk. But what if you have risk factors? How do you know if you’re at greater risk... Continue Reading

March Is National Colorectal Cancer Awareness Month (March 12, 2015)

OMNI Health Media (OMNI) announces the launch of colorectal cancer programs for national colorectal cancer awareness month. As the month of March brings colorectal cancer into focus, it’s time to increase... Continue Reading

Novel PD-1 Inhibitor Opdivo Approved for Treatment of Lung Cancer (March 11, 2015)

CancerConnect News: The Food and Drug Administration has expanded approval of the PD-1 inhibitor Opdivo® (nivolumab) to include treatment of patients who have metastatic squamous non–small cell lung... Continue Reading

Infection with Hepatitis C Increases Risk of Cirrhosis (March 10, 2015)

People who are infected with the hepatitis C virus (HCV) have a higher risk for developing the liver disease cirrhosis, particularly within the first five years after infection. These findings were released... Continue Reading

Study Suggests Faslodex® Could Become New Standard First-Line Treatment of Metastatic Breast Cancer (March 9, 2015)

CancerConnect News: Faslodex® (fulvestrant) at a 500-mg dose has been demonstrated to be superior to Arimidex® (anastrozole) as first-line therapy for advanced hormone receptor–positive breast cancer... Continue Reading

National Kidney Cancer Awareness Month on CancerConnect (March 6, 2015)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of kidney cancer educational programs for national kidney cancer awareness month. As the month of March brings kidney... Continue Reading

The Novel Small Molecule Pictilisib May Benefit Women with Advanced Breast Cancer (March 5, 2015)

CancerConnect News:  The addition of the investigational drug pictilisib to Faslodex® (fulvestrant) has been demonstrated to delay the time of cancer in women with advanced or metastatic breast cancer... Continue Reading

More Cancer News

CancerConnect Cancer Commuity & Discussions


Cancer Types



Headline News by Cancer Type


Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS